Middle Aged

Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study
OBJECTIVES: Insight into the most important inflammatory pathways in ankylosing spondylitis (AS) could be of importance in risk …
S. H. Sveaas, I. J. Berg, S. A. Provan, A. G. Semb, I. C. Olsen, T. Ueland, P. Aukrust, N. Vøllestad, K. B. Hagen, T. K. Kvien, H. Dagfinrud
Cite DOI
EULAR task force recommendations on annual cardiovascular risk assessment for patients with rheumatoid arthritis: an audit of the success of implementation in a rheumatology outpatient clinic
OBJECTIVE: EULAR recommendations for cardiovascular disease (CVD) risk management include annual CVD risk assessments for patients with …
Eirik Ikdahl, Silvia Rollefstad, Inge C. Olsen, Tore K. Kvien, Inger Johanne Widding Hansen, Dag Magnar Soldal, Glenn Haugeberg, Anne Grete Semb
Cite DOI
Health status has improved more in women than in men with rheumatoid arthritis from 1994 to 2009: results from the Oslo rheumatoid arthritis register
OBJECTIVE: To examine changes in patient reported outcome measures (PROs) over 15 years in a representative population of patients with …
C. Austad, T. K. Kvien, I. C. Olsen, T. Uhlig
Cite DOI
Uveitis is associated with hypertension and atherosclerosis in patients with ankylosing spondylitis: a cross-sectional study
OBJECTIVES: Uveitis is the most common extra-articular manifestation in patients with ankylosing spondylitis (AS), but the literature …
Inger Jorid Berg, Anne Grete Semb, Désirée van der Heijde, Tore K. Kvien, Jonny Hisdal, Inge C. Olsen, Hanne Dagfinrud, Sella A. Provan
Cite DOI
Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity
OBJECTIVE: To assess the predictive value of magnetic resonance imaging (MRI)-detected subclinical inflammation for subsequent …
Frédérique Gandjbakhch, Espen A. Haavardsholm, Philip G. Conaghan, Bo Ejbjerg, Violaine Foltz, Andrew K. Brown, Uffe Møller Døhn, Marissa Lassere, Jane E. Freeston, Inge Christoffer Olsen, Pernille Bøyesen, Paul Bird, Bruno Fautrel, Merete Lund Hetland, Paul Emery, Pierre Bourgeois, Kim Hørslev-Petersen, Tore K. Kvien, Fiona M. McQueen, Mikkel Østergaard
Cite DOI
Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study
BACKGROUND: Physical therapy is recommended for the management of axial spondyloarthritis (axSpA) and flexibility exercises have …
Silje Halvorsen Sveaas, Inger Jorid Berg, Sella Aarrestad Provan, Anne Grete Semb, Kåre Birger Hagen, Nina Vøllestad, Camilla Fongen, Inge C. Olsen, Annika Michelsen, Thor Ueland, Pål Aukrust, Tore K. Kvien, Hanne Dagfinrud
Cite DOI
Carotid plaque characteristics and disease activity in rheumatoid arthritis
OBJECTIVE: Carotid plaques (CP) are predictive of acute coronary syndrome in patients with rheumatoid arthritis (RA), suggesting that …
Anne G. Semb, Silvia Rollefstad, Sella A. Provan, Tore K. Kvien, Einar Stranden, Inge C. Olsen, Jonny Hisdal
Cite DOI
Associations between APOE genotypes and disease susceptibility, joint damage and lipid levels in patients with rheumatoid arthritis
OBJECTIVE: Apolipoprotein E (APOE) genotypes are associated with cardiovascular disease (CVD) and lipid levels. In rheumatoid arthritis …
Marthe T. Maehlen, Sella A. Provan, Diederik P. C. de Rooy, Annette H. M. van der Helm-van Mil, Annemarie Krabben, Tore Saxne, Elisabet Lindqvist, Anne Grete Semb, Till Uhlig, Désirée van der Heijde, Inger Lise Mero, Inge C. Olsen, Tore K. Kvien, Benedicte A. Lie
Cite DOI
A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
The clinical profile of ibandronate as add-on to calcitriol and calcium was studied in this double-blind, placebo-controlled trial of …
K. T. Smerud, S. Dolgos, I. C. Olsen, A. Åsberg, S. Sagedal, A. V. Reisæter, K. Midtvedt, P. Pfeffer, T. Ueland, K. Godang, J. Bollerslev, A. Hartmann
Cite DOI
ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial
OBJECTIVE: To investigate whether ω-3 fatty acids reduce magnetic resonance imaging (MRI) and clinical disease activity in patients …
Oivind Torkildsen, Stig Wergeland, Søren Bakke, Antonie G. Beiske, Kristian S. Bjerve, Harald Hovdal, Rune Midgard, Finn Lilleås, Tom Pedersen, Bård Bjørnarå, Frøydis Dalene, Grethe Kleveland, Jan Schepel, Inge Christoffer Olsen, Kjell-Morten Myhr
Cite DOI